Eli Lilly Lyumjev gets USFDA okay for use in insulin pumps ruchika19 Aug 2021 5:30 AM GMTIndianapolis: Eli Lilly and Company has recently announced that the Food and Drug Administration (USFDA) has approved an expanded label for the company...
Exclude patients with history of TB from Baricitinib clinical study for Atopic Dermatitis: CDSCO panel tells Eli Lilly Medical Dialogues Team15 Jun 2021 11:26 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has asked Eli Lilly to conduct a clinical...
Eli Lilly antibody drugs bamlanivimab, etesevimab get nod for use in India ruchika1 Jun 2021 6:30 AM GMTNew Delhi: Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 m...
Eli Lilly, BDR Pharma ink pact for COVID drug Baricitinib ruchika23 May 2021 3:30 AM GMTNew Delhi: Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution ...
Natco Pharma enters agreement with Eli Lilly for COVID drug Baricitinib ruchika18 May 2021 6:21 AM GMTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with El...
Torrent Pharma, Eli Lilly ink pact to boost Baricitinib production in India ruchika14 May 2021 9:53 AM GMTAhmedabad: Following in the footsteps of Sun Pharma, Cipla, and Lupin in signing a voluntary licencing agreement with Eli Lilly to accelerate the ...
Dr Reddys, Eli Lilly collaborate for manufacturing, commercializing Baricitinib in India ruchika13 May 2021 3:45 AM GMTHyderabad: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced that the company has entered into a royalty-free, non-exclusive voluntary...
Combating COVID: Eli Lilly accelerating baricitinib availability in India ruchika6 May 2021 6:30 AM GMTIndianapolis: Eli Lilly and Company has recently announced new initiatives to help COVID-19 patients in India as part of its commitment to b...
Eli Lilly, Asahi Kasei Pharma ink license agreement for chronic pain drug candidate ruchika31 Jan 2021 4:00 AM GMTIndianapolis and Tokyo:Eli Lilly and Company and Asahi Kasei Pharma Corporation have recently announced a license agreement whereby Lilly wil...
Eli Lilly to Acquire Prevail Therapeutics in USD 1.04 Billion deal ruchika16 Dec 2020 9:24 AM GMTIndianapolis, New York: Eli Lilly and Company and Prevail Therapeutics Inc. have announced a definitive agreement for Lilly to acquire P...
Eli Lilly to supply 650,000 additional Covid doses to US Govt ruchika4 Dec 2020 4:30 AM GMTNew Delhi: Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its Covid-19 antibody drug for $812.5 milli...
Eli Lilly arthritis drug baricitinib in combination with remdesivir gets USFDA okay to treat Covid ruchika22 Nov 2020 5:30 AM GMTNew Delhi: The U.S. Food and Drug Administration on Thursday approved the emergency use of Eli Lilly and Co's arthritis drug, baricitinib, in combinati...
